AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.800
-0.080 (-2.78%)
At close: Dec 5, 2025, 4:00 PM EST
2.779
-0.021 (-0.75%)
After-hours: Dec 5, 2025, 7:51 PM EST
AC Immune Market Cap
AC Immune has a market cap or net worth of $277.04 million as of December 5, 2025. Its market cap has decreased by -15.15% in one year.
Market Cap
277.04M
Enterprise Value
146.86M
1-Year Change
-15.15%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $277.04M, a decrease of -68.06%. That is a compound annual growth rate of -11.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 282.50M | 4.78% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |